iMDx to Release First Quarter 2026 Results on May 13, 2026

Rhea-AI Summary

Insight Molecular Diagnostics (Nasdaq: IMDX) will release its first quarter 2026 financial results after market close on May 13, 2026. A live Zoom webinar to discuss results and host Q&A is scheduled for 2:00 pm PT / 5:00 pm ET that day, with registration required. An archived replay will be posted in the Investors/Events & Presentations section of iMDX’s website after the call.

News Market Reaction – IMDX

-1.39%

7 alerts

-1.39% Session close to close

+4.1% Peak Tracked

-3.3% Trough Tracked

$162.73M Market Cap

0.8x Rel. Volume

In the May 7 session, IMDX declined 1.39%, reflecting a mild negative market reaction. Argus tracked a peak move of +4.1% during that session. Argus tracked a trough of -3.3% from its starting point during tracking. Our momentum scanner triggered 7 alerts that day, indicating moderate trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement schedules IMDX’s Q1 2026 results for May 13, 2026, with a live webinar at 2:00 pm ...

Analysis

This announcement schedules IMDX’s Q1 2026 results for May 13, 2026, with a live webinar at 2:00 pm PT / 5:00 pm ET. It follows a prior earnings-date release that preceded a +8.67% move, highlighting that timing updates can still matter. In light of recent clinical and regulatory progress, investors may focus on revenue trends, cash levels, and any commentary on commercialization and spending plans during the upcoming call.

Key Figures

Earnings report date: May 13, 2026 Webinar time PT: 2:00 pm PT Webinar time ET: 5:00 pm ET

3 metrics

Earnings report date May 13, 2026 Q1 2026 results to be reported after market close

Webinar time PT 2:00 pm PT Live Zoom webinar to discuss Q1 2026 results

Webinar time ET 5:00 pm ET Same-day Q1 2026 results discussion with Q&A

Previous Earnings date Reports

1 past event · Latest: Mar 20 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Mar 20	Earnings date announcement	Neutral	+8.7%	Set Q4 2025 earnings date and investor webinar with conference participation.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior earnings-date scheduling news coincided with a positive share move on the following day.

Recent Company History

Recent IMDX news has focused on advancing its GraftAssureDx platform, regulatory submissions, and capital raises. Notably, a prior earnings date announcement on Mar 20, 2026 preceded a +8.67% move, while clinical and regulatory milestones in March–April also saw double-digit reactions in both directions. Today’s Q1 2026 earnings-date release continues the pattern of pairing financial reporting with investor-accessible webinars for updates.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

NASHVILLE, Tenn., May 06, 2026 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., (Nasdaq: IMDX), (iMDx), today announced that it will report first quarter 2026 financial results after the market closes on Wednesday, May 13, 2026, then host a live Zoom webinar to discuss the company's financial results at 2:00 pm PT / 5:00 pm ET that same day.

The live webinar to discuss financial results, followed by Q&A, will be accessible via registration at the following link: iMDX Q1 2026 Earnings Webinar.

An archived replay will be available after the call concludes on iMDX’s website within the Investors/Events & Presentations section here.

About Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. Investors may visit https://investors.imdxinc.com/ for more information.

GraftAssureCore™, GraftAssureIQ™, GraftAssureDx™, VitaGraft™, GraftAssure™, DetermaIO™, and DetermaCNI™ are trademarks of Insight Molecular Diagnostics Inc.

Investor Contact:
Alexandra Grossman
LifeSci Advisors LLC
imdx@lifesciadvisors.com 

FAQ

When will IMDX release its Q1 2026 earnings and when is the follow-up webinar?

IMDX will release Q1 2026 results after market close on May 13, 2026. According to the company, a live Zoom webinar will follow on May 13, 2026 at 2:00 pm PT / 5:00 pm ET to discuss results and host Q&A.

How can investors register for the IMDX Q1 2026 earnings webinar (IMDX)?

Investors can register via the company’s designated webinar link provided by IMDX. According to the company, registration is required to access the live Zoom webinar and participate in the Q&A session on May 13, 2026.

Will there be a replay of the IMDX Q1 2026 earnings webinar and where is it posted?

Yes. According to the company, an archived replay will be available after the call concludes. The replay will be posted in the Investors/Events & Presentations section of iMDX’s website for later viewing.

What time should shareholders tune in for IMDX's May 13, 2026 earnings presentation (IMDX)?

Shareholders should join the live webinar at 2:00 pm PT / 5:00 pm ET on May 13, 2026. According to the company, the webinar will cover the first quarter 2026 financial results and include a live Q&A session.

Will IMDX disclose Q1 2026 financial details during the webinar or only in the release?

IMDX will first issue the Q1 2026 financial results after market close and then discuss those results during the webinar. According to the company, the live Zoom event will review the results and offer a Q&A with management.